Cancer Immunology Immunotherapy, 0340-7004

Journal

1 - 10 out of 13Page size: 10

Publications

  1. 2020
  2. E-pub ahead of print

    The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer

    Akshay Patel, Alex Richter, Mark Drayson & Gary Middleton, 4 Jan 2020, In : Cancer Immunology Immunotherapy.

    Research output: Contribution to journal › Article

  3. 2019
  4. Published

    Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2

    Leila Khoja & 24 others, , 1 May 2019, In : Cancer Immunology Immunotherapy. 68, 5, p. 773-785 13 p.

    Research output: Contribution to journal › Article

  5. 2015
  6. Published

    Developments in cancer vaccines for hepatocellular carcinoma

    Yuk Ting Ma & David Adams, 21 Jun 2015, In : Cancer Immunology Immunotherapy. 65, 93.

    Research output: Contribution to journal › Article

  7. 2014
  8. Published

    The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer

    Lucinda Billingham & Gary Middleton, Feb 2014, In : Cancer Immunology Immunotherapy. 63, 2, p. 175-83 9 p.

    Research output: Contribution to journal › Article

  9. 2012
  10. Published

    Are we ready to start studies of Th17 cell manipulation as a therapy for cancer?

    Gary Middleton, Nicola Annels, 2012, In : Cancer Immunology Immunotherapy. 61, 1, p. 1-7 7 p.

    Research output: Contribution to journal › Article

  11. 2011
  12. Published

    Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12

    Alex Dowell, Steve Lee & Peter Searle, 22 Oct 2011, In : Cancer Immunology Immunotherapy.

    Research output: Contribution to journal › Article

  13. Published

    Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13

    Deborah Stocken, 1 Oct 2011, In : Cancer Immunology Immunotherapy. 60, 10, p. 1419-1430 12 p.

    Research output: Contribution to journal › Article

  14. Published

    Dominant responses with conservation of T-cell receptor usage in the CD8+ T-cell recognition of a cancer testis antigen peptide presented through HLA-Cw7 in patients with multiple myeloma.

    Oliver Goodyear, Dickens Pratt & Paul Moss, 23 Jul 2011, In : Cancer Immunology Immunotherapy.

    Research output: Contribution to journal › Article

  15. 2009
  16. Published

    Expression and function of T cell homing molecules in Hodgkin's lymphoma.

    Paul Murray, Neil Steven, David Adams & Steve Lee, 1 Jan 2009, In : Cancer Immunology Immunotherapy. 58, 1, p. 85-94 10 p.

    Research output: Contribution to journal › Article

  17. 2008
  18. Published

    The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-delta dependent manner

    Peter Hampson, Dean Kavanagh, Emily Smith, Ke-Qing Wang, Janet Lord & Ed Rainger, 1 Aug 2008, In : Cancer Immunology Immunotherapy. 57, 8, p. 1241-51 11 p.

    Research output: Contribution to journal › Article

Previous 1 2 Next